Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - therapeutic%3a+small+molecule
5
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Novel treatment for CTNNB1 syndrome
SUMMARY Tufts University investigator, Michelle Jacob, and Broad Institute’s Florence Wagner, have shown significant improvements in symptoms of CTNNB1 neurodevelopmental disorder in a heterozygous mouse model using a novel small molecule targeting β-catenin signaling. BACKGROUND The CTNNB1 mutation is an extremely rare genetic neurodevelopmental...
Published: 4/29/2024
|
Inventor(s):
Michele Jacob
,
Jonathan Alexander
,
Florence Wagner
Keywords(s):
Category(s):
Therapeutic
,
Therapeutic: small molecule
AdipoAI: An Adiponectin Receptor Agonist for Treatment of Inflammation and Diabetes
BACKGROUND Adiponectin (APN) is an endogenous protein hormone which binds to Adiponectin Receptors 1 and 2 to exert an anti-inflammatory response and regulate glucose and fatty acid metabolism. Low APN levels in serum are associated with an increased risk of metabolic diseases and inflammatory disorders such as Type 2 Diabetes (T2D), heart disease,...
Published: 4/29/2024
|
Inventor(s):
Jinkun (Jake) Chen
,
Qisheng Tu
,
Xingwen Wu
Keywords(s):
Category(s):
Therapeutic
,
Therapeutic: anti-inflammatory
,
Therapeutic: small molecule
Inhibitors of Clostridium difficile spore germination and outgrowth
Inhibitors of Clostridium difficile spore germinationTufts case T001523Technology• Spore formation by Clostridium difficile is a significant obstacle to overcoming hospital-acquired C. difficile-associated disease (CDAD). Spores are resistant to heat, radiation, chemicals, and antibiotics, making a contaminated environment difficult to clean....
Published: 3/19/2021
|
Inventor(s):
Abraham Sonenshein
,
Joseph Sorg
Keywords(s):
Category(s):
Diseases: infectious
,
Screening: target
,
Therapeutic: antibiotic
,
Therapeutic: small molecule
Novel small molecule inhibitors of phosphatidylinositol-3,4,5-trisphosphate (PIP3)
Why is the target important?The PI3 lipid kinase (PI3K) pathway is an important target for anti-cancer drug development because:It’s activated by growth factors, oncogenes (RAS), GPCRs, etc. It regulates an array of critical cellular functions, including survival, proliferation, metabolism and cell motility. PI3K and its downstream effectors are...
Published: 3/19/2021
|
Inventor(s):
Alexei Degterev
,
Benchun Miao
,
C.v. Ramana
Keywords(s):
Category(s):
Diseases: cancer
,
Therapeutic: small molecule
Highly Stereoselective Glycosylation Reactions
Researchers at Tufts University have developed a new method to generate 1,2-cis-a-glycosides without the need for specialized directing groups. The new synthetic approach uses thioglycoside donors, which are shelf-stable and easily adapted to one-pot oligosaccharide synthesis. This is a critical technological development for the iterative synthesis...
Published: 6/5/2020
|
Inventor(s):
Clay Bennett
,
An-Hsiang Chu
Keywords(s):
Category(s):
Chemistry
,
Chemistry: organic compounds
,
Therapeutic: cell signalling
,
Therapeutic: small molecule
,
Therapeutic: vaccine